Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05424757 · ClinicalTrials.gov registry record
Polyethylene Glycol Safety in Children
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 158
- Enrollment target
NCT05424757 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 158 participants.
The verdict
NCT05424757 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 158 participants
- Enrollment target
Study Summary
The primary objective is to measure levels of selected PEG 3350 components and metabolites in the blood and urine of children who are already taking PEG 3350 compared to children who are not taking PEG 3350. Changes to medical therapy are not recommended as part of this study.
Interventions
- DRUG PEG 3350
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2022-09-30 |
| Est. Completion | 2025-08-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05424757
The ClinicalTrials.gov registry entry for NCT05424757 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PEG 3350 is the first listed.
NCT05424757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05424757 about?
NCT05424757 is a clinical study titled "Polyethylene Glycol Safety in Children". The primary objective is to measure levels of selected PEG 3350 components and metabolites in the blood and urine of children who are already taking PEG 3350 compared to children who are not taking PEG 3350. Changes to medical therapy are not recommended as part of this study.
What is the current status of trial NCT05424757?
This trial is currently completed. The enrollment target is 158 participants. The study started on 2022-09-30. Estimated completion is 2025-08-09.
What interventions are being tested in trial NCT05424757?
The interventions under investigation include: PEG 3350 (DRUG).
Who is sponsoring clinical trial NCT05424757?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.